4349 E Durham CirStone Mountain, GA 30083 United States The Mission of LemonAid Brunch is to help men, women, and children cope and overcome obstacles in a healthy way. Our primary focus is mental ...

The DNA-testing firm said in a Tuesday SEC filing, “there is substantial doubt about the company’s ability to continue.” ...

23andMe's big push into drug development, announced with great fanfare almost a decade ago, has ended with a whimper and ...

SUNNYVALE, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics and preventive health company, ...

Beyond personal genetics, it operates Lemonaid telehealth for easy access to medical consultations. In the realm of drug development, 23andMe is actively working on novel therapies in areas like ...

If they have high levels, they can then be connected to clinicians through 23andMe’s telehealth arm – Lemonaid – to get advice on the next steps. At the moment, there is no treatment that ...

Advancements and Projections in the AI in Telemedicine Market: Insights, Trends, Opportunities, and Recent DevelopmentsNew ...

Ali Truwit can do anything she puts her mind to. The Paralympic swimmer, who was a victim of a shark attack in Turks and ...

Petros Pharmaceuticals, Inc. (PTPI)股票已达到新的52周低点，交易价格为0.28美元，标志着公司市值出现显著下滑。这一最新价格反映了过去一年的急剧下跌，与上一年相比，股价变动幅度为-77.27%。投资者正密切关注公司的表现，因为这一新低可能预示着潜在的挑战，或对那些相信公司长期前景的人来说可能是一个买入机会。市场对这一新的52周低点的反应将反映出对Petros ...

在充满挑战的市场环境中，23andMe Holding Co. (ME)的股价已达到52周低点，跌至4.33美元。这家基因测试和分析公司在过去一年面临重大阻力，股价表现反映了这一点，一年来变化幅度高达-69.8%。投资者对公司的增长前景和竞争压力表示担忧，这些因素导致了股价的下行趋势。目前的价格水平对23andMe来说是一个关键时刻，公司正努力重获投资者信心并转向更可持续的增长路径。 在其他近期新 ...